XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue:        
Revenue $ 118,262 $ 89,839 $ 344,292 $ 244,923
Cost of sales 38,215 30,323 129,279 80,715
Gross profit 80,047 59,516 215,013 164,208
Operating expenses:        
Research and development 20,000 12,111 47,831 32,429
Sales, general and administrative 91,411 75,954 269,960 218,093
Litigation-related expenses 2,715 3,602 12,815 16,629
Amortization of acquired intangible assets 3,873 2,774 10,461 7,181
Transaction-related expenses 278   2,178 120
Restructuring expenses 129 45 333 1,704
Total operating expenses 118,406 94,486 343,578 276,156
Operating loss (38,359) (34,970) (128,565) (111,948)
Interest expense and other expense, net:        
Interest expense, net (4,459) (1,285) (12,225) (4,176)
Other income (expense), net 47 (615) 3,077 (578)
Total interest expense and other expense, net (4,412) (1,900) (9,148) (4,754)
Net loss before taxes (42,771) (36,870) (137,713) (116,702)
Income tax benefit (117) (77) (153) (192)
Net loss $ (42,654) $ (36,793) $ (137,560) $ (116,510)
Net loss per share, basic $ (0.35) $ (0.35) $ (1.18) $ (1.14)
Net loss per share, diluted $ (0.35) $ (0.35) $ (1.18) $ (1.14)
Weighted average shares outstanding, basic 122,468 104,804 117,026 102,561
Weighted average shares outstanding, diluted 122,468 104,804 117,026 102,561
Products and Services        
Revenue:        
Revenue $ 118,262 $ 89,839 $ 344,292 $ 244,908
International Supply Agreement        
Revenue:        
Revenue       $ 15